(Q37888736)

24 August 2017

1 reference

title

Gastrointestinal stromal tumours--an update for histopathologists (English)

1 reference

24 August 2017

Newton A C S Wong

1

1 reference

24 August 2017

publication date

13 June 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

59

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

807-821

1 reference

Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Gastrointestinal stromal tumors in Iceland, 1990-2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Gastrointestinal stromal tumors: key to diagnosis and choice of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Antigen retrieval and primary antibody type affect sensitivity but not specificity of CD117 immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Specificity of DOG1 (K9 clone) and protein kinase C theta (clone 27) as immunohistochemical markers of gastrointestinal stromal tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

An update on molecular genetics of gastrointestinal stromal tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

KRAS mutation testing in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Gain-of-function PDGFRA mutations, earlier reported in gastrointestinal stromal tumors, are common in small intestinal inflammatory fibroid polyps. A study of 60 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

KIT as a therapeutic target in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Gastrointestinal stromal tumors: pathology and prognosis at different sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Molecular characterization of pediatric gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Risk stratification of patients diagnosed with gastrointestinal stromal tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Activity of dasatinib, a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against gastrointestinal stromal tumor-associated PDGFRAD842V mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Heterogeneity of kinase inhibitor resistance mechanisms in GIST

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Pathological changes related to Imatinib treatment in a patient with a metastatic gastrointestinal stromal tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

The lessons of GIST--PET and PET/CT: a new paradigm for imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Follow-up of hepatic and peritoneal metastases of gastrointestinal tumors (GIST) under Imatinib therapy requires different criteria of radiological evaluation (size is not everything!!!).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Familial gastrointestinal stromal tumors caused by the novel KIT exon 17 germline mutation N822Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Pediatric gastrointestinal stromal tumors and leiomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Gastrointestinal stromal tumor of the prostate: a case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Extragastrointestinal stromal tumor presenting as a scrotal mass: an unusual case

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Primary gastrointestinal stromal tumor of the liver: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Extragastrointestinal stromal tumor arising in the rectovaginal septum: report of an unusual case with literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Reclassification of a tubal leiomyosarcoma as an eGIST by molecular evaluation of c-KIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Progesterone receptor activity in leiomyomatosis peritonealis disseminata

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Retroperitoneal leiomyomas: a clinicopathologic and immunohistochemical study of 56 cases with a comparison to retroperitoneal leiomyosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Primary extragastrointestinal stromal tumor of the pleura: report of a unique case with genetic confirmation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

BRAF mutation status in gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

BRAF inhibitor unveils its potential against advanced melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

Strong expression of IGF1R in pediatric gastrointestinal stromal tumors without IGF1R genomic amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03812.X

10.1111/J.1365-2559.2011.03812.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference